RetractedArticlePsychopharmacology bulletin2017
A Phase-1, 6-Month Open-Label, Dose-Ranging Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant.
Ryan Dammerman et al.PubMed ↗
No numbers read from the abstract.
1 paper cites it
this papercites it